effect of amiodarone in reducing the incidence of atrial fibrilatio
Phase 2
- Conditions
- Atrial fibrillation.??????????? ?????? ? ?????
- Registration Number
- IRCT2013112215490N1
- Lead Sponsor
- Arak University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 204
Inclusion Criteria
1.All patients candidate for CABG
2.All patients with ASA II and III.
3.All surveyed patients are candidate for 2 or 3 grafts.
Exclusion criteria:
1.Patients candidate for more than 3 grafts.
2.Incidence of any arrhythmia in placebo group.
3.Incidence of any arrhythmia other than atrial fibrillation in the amiodarone group.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atrial fibrilation. Timepoint: within 48 hours after surgery. Method of measurement: Cardiac monitoring.
- Secondary Outcome Measures
Name Time Method